These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31419483)

  • 1. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
    Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
    Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
    Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial.
    Bížová B; Procházka P; Nyčová E; Bořil P; Kubele J; Poláková A; Zemanová Z; Unemo M; Rob F
    Clin Microbiol Infect; 2024 Feb; 30(2):211-215. PubMed ID: 37981059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
    Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW
    Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
    Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
    Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
    Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' - Author's reply.
    Rob F; Unemo M
    Clin Microbiol Infect; 2020 Jun; 26(6):799-800. PubMed ID: 32120033
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: 'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' by Rob et al.
    Sfeir MM
    Clin Microbiol Infect; 2020 Jun; 26(6):797-798. PubMed ID: 32035231
    [No Abstract]   [Full Text] [Related]  

  • 12. Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
    Cole MJ; Tan W; Fifer H; Brittain C; Duley L; Hepburn T; Lawrence T; Montgomery AA; Sprange K; Thandi S; Churchward C; Tripodo F; Woodford N; Ross JDC
    J Antimicrob Chemother; 2020 Feb; 75(2):449-457. PubMed ID: 31670808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.
    de Vries HJC; de Laat M; Jongen VW; Heijman T; Wind CM; Boyd A; de Korne-Elenbaas J; van Dam AP; Schim van der Loeff MF;
    Lancet Infect Dis; 2022 May; 22(5):706-717. PubMed ID: 35065063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.
    Levy V; Pandori M; Berrada ZL; Relucio KI; Lopez TP; Samuel MC; Park IU
    Sex Transm Dis; 2016 Apr; 43(4):258-9. PubMed ID: 26967304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.
    Handsfield HH; Dalu ZA; Martin DH; Douglas JM; McCarty JM; Schlossberg D
    Sex Transm Dis; 1994; 21(2):107-11. PubMed ID: 9071422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin Alone Is Inadequate to Eradicate Neisseria Gonorrhoeae From the Pharynx.
    Barbee LA; Soge OO; Morgan J; Leclair A; Bass T; Werth BJ; Hughes JP; Golden MR
    Clin Infect Dis; 2020 Nov; 71(8):1877-1882. PubMed ID: 31712813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial.
    Rubio FG; Cunha CA; Lundgren FL; Lima MP; Teixeira PJ; Oliveira JC; Golin V; Mattos WL; Mählmann HK; Moreira ED; Jardim JR; Silva RL; Silva PH
    Braz J Infect Dis; 2008 Jun; 12(3):202-9. PubMed ID: 18833404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
    Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
    N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].
    Nenoff P; Manos A; Ehrhard I; Krüger C; Paasch U; Helmbold P; Handrick W
    Hautarzt; 2017 Jan; 68(1):43-49. PubMed ID: 27981386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.